Cognitive training with psilocybin for brain flexibility
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether combining a brain-training program with a psychedelic drug called psilocybin can boost the brain's ability to change and adapt. It may help improve thinking and memory.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have not yet been fully screened, but you will need to meet initial criteria set by the study team.
- You must be willing to participate in cognitive training sessions.
- You must be willing to take psilocybin as part of the study.
- You must be willing to follow safety guidelines and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether psilocybin (a psychedelic substance) can help with depression in people who have mild memory problems or early Alzheimer’s. The trial also closely monitors safety, thinking changes, mood, and blood pressure before and after dosing.
This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.
This trial tests whether psilocybin, a psychedelic drug, can safely help with depression in people with ALS. It also looks at how the drug affects your symptoms and quality of life over six months.
This study tests whether combining mindfulness training with a single dose of psilocybin (a psychedelic found in certain mushrooms) can help healthy adults. It aims to explore how these two approaches together might improve well-being.
This study looks at how a single dose of psilocybin (the active ingredient in magic mushrooms) affects brain structure in healthy older adults. You'll receive the drug in a safe setting and have brain scans before and after to see if it promotes positive changes.
This study tests how psilocybin, a substance that can cause hallucinations, affects memory and brain activity in healthy adults. It may help us understand how psilocybin could be used for mental health treatments.
Hear when a new Alzheimer’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.